A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 17 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors

Comparison hub

Comparison hub

In this section, you can compare what actions the 17 pharmaceutical companies in scope are taking to limit AMR. All of the figures and analyses per Research Area from the report cards can be compared, for a maximum of three companies. For example, you can compare number of projects in the pipeline or products on the market. Or, take a look at the revenue per product or region, for each company.

Select up to 3 companies to start comparing or dive into a full report card

Select topics for comparison Select all topics

Get in touch

Back to top |